Skip to main content
Livermore
Livermore
ZHEN

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

NVS holding history

Novartis AG in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
1,001
Value
$156.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVS by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,001$156.9K<0.1%00.0%UnchangedHolders
Q1 20261,001$153.0K<0.1%00.0%UnchangedHolders
Q4 20251,001$138.1K<0.1%−8−0.8%ReducedHolders
Q3 20251,009$129.4K<0.1%00.0%UnchangedHolders
Q2 20251,009$122.1K<0.1%−9−0.9%ReducedHolders
Q1 20251,018$113.5K<0.1%−22−2.1%ReducedHolders
Q4 20241,040$101.2K<0.1%00.0%UnchangedHolders
Q3 20241,040$119.6K<0.1%00.0%UnchangedHolders
Q2 20241,040$110.7K<0.1%00.0%UnchangedHolders
Q1 20241,040$100.6K<0.1%+50+5.1%AddedHolders
Q4 2023990$100.0K<0.1%+712+256.1%AddedHolders
Q3 2023278$28.4K<0.1%−1−0.4%ReducedHolders
Q2 2023279$28.1K<0.1%+1+0.4%AddedHolders
Q1 2023278$25.6K<0.1%−75−21.2%ReducedHolders
Q4 2022353$32.1K<0.1%00.0%UnchangedHolders
Q3 2022353$26.9K<0.1%00.0%UnchangedHolders
Q2 2022353$29.9K<0.1%00.0%UnchangedHolders
Q1 2022353$31.0K<0.1%00.0%UnchangedHolders
Q4 2021353$30.9K<0.1%−100−22.1%ReducedHolders
Q3 2021453$37.1K<0.1%00.0%UnchangedHolders
Q2 2021453$41.4K<0.1%+30+7.1%AddedHolders
Q1 2021423$36.2K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.